Ensign Peak Advisors’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-16,300
Closed -$304K 1741
2023
Q3
$304K Hold
16,300
﹤0.01% 1690
2023
Q2
$423K Buy
16,300
+1,400
+9% +$37.5K ﹤0.01% 1665
2023
Q1
$428K Buy
14,900
+4,200
+39% +$125K ﹤0.01% 1670
2022
Q4
$317K Buy
10,700
+4,600
+75% +$131K ﹤0.01% 1702
2022
Q3
$145K Hold
6,100
﹤0.01% 1988
2022
Q2
$136K Hold
6,100
﹤0.01% 1901
2022
Q1
$153K Hold
6,100
﹤0.01% 1946
2021
Q4
$219K Sell
6,100
-9,700
-61% -$388K ﹤0.01% 1907
2021
Q3
$672K Hold
15,800
﹤0.01% 1558
2021
Q2
$684K Hold
15,800
﹤0.01% 1539
2021
Q1
$644K Hold
15,800
﹤0.01% 1554
2020
Q4
$715K Sell
15,800
-200
-1% -$7.59K ﹤0.01% 1515
2020
Q3
$566K Hold
16,000
﹤0.01% 1500
2020
Q2
$604K Hold
16,000
﹤0.01% 1421
2020
Q1
$463K Hold
16,000
﹤0.01% 1410
2019
Q4
$830K Buy
+16,000
New +$929K ﹤0.01% 1396

Other funds holding ANIK